Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 4.42% | 142.28 | 0.0% | $911.73m | |
| AMGN | Amgen, Inc. | 0.61% | 245.35 | 1.5% | $794.97m | |
| GILD | Gilead Sciences, Inc. | 1.51% | 63.18 | 1.0% | $521.21m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.02% | 261.84 | 1.9% | $460.53m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.92% | 667.56 | 2.6% | $410.61m | |
| NVAX | Novavax, Inc. | 8.23% | 51.95 | 75.7% | $297.33m | |
| ILMN | Illumina, Inc. | 4.06% | 243.22 | 3.3% | $294.25m | |
| BIIB | Biogen, Inc. | 2.28% | 202.90 | 1.8% | $245.50m | |
| BNTX | BioNTech SE | 5.69% | 159.80 | 0.0% | $220.63m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -1.41% | 2.10 | 0.7% | $146.80m | |
| EXAS | EXACT Sciences Corp. | 7.04% | 54.11 | 17.7% | $143.36m | |
| NKTX | Nkarta, Inc. | -0.36% | 13.81 | 0.0% | $106.92m | |
| TECH | Bio-Techne Corp. | 2.46% | 371.05 | 4.5% | $99.46m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.33% | 79.12 | 4.2% | $99.12m | |
| TXG | 10X Genomics, Inc. | 6.83% | 49.46 | 0.0% | $94.47m |
Company Profile
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.